Laddar...
DOAC‐Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples
BACKGROUND: The use of direct oral anticoagulants (DOACs) is a convenient therapeutic option for patients at risk of thrombosis. DOACs interfere with clot‐based testing for the identification of lupus anticoagulant antibodies (LACs) in patients with antiphospholipid syndrome (APS), a common cause of...
Sparad:
| I publikationen: | Res Pract Thromb Haemost |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley and Sons Inc.
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7938630/ https://ncbi.nlm.nih.gov/pubmed/33733031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12472 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|